News

Consumers fight to halt move towards direct to consumer advertising in Europe

BMJ 2007; 334 doi: 10.1136/bmj.39212.645486.DB (Published 17 May 2007)
Cite this as: BMJ 2007;334:1025.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ray Moynihan
  1. Byron Bay

    An international alliance of consumer and other groups has attacked the European Commission, accusing it of supporting the drug industry's push for direct to consumer advertising in Europe.

    US-style advertising of prescription drugs aimed directly at consumers is currently prohibited in Europe, and attempts to overturn the ban were firmly rejected by the European parliament in 2002 (BMJ 2002;325:990 doi: 10.1136/bmj.325.7371.990/a).

    However, the drug industry and elements within the European Commission are pushing to change the rules so that drug companies can provide more information to patients across Europe, a move that critics argue is an underhand way of introducing advertising.

    Taking a position in support of loosening the rules, a European Commission draft report that is currently out …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular